Be part of the knowledge.™

Oncology and Hematology

1027

LikeLikedUnlike

1-15 of 323

Treatment Decisions That Matter: Live Tumor Board in Advanced Ovarian Cancer
CME/CE Virtual Event
Treatment Decisions That Matter: Live Tumor Board in Advanced Ovarian Cancer
August 20, 2026
02:30 PM - 03:30 PM ET
1.00 credits
Treatment Decisions That Matter: Live Tumor Board in Advanced Ovarian Cancer
CME/CE Virtual Event
Treatment Decisions That Matter: Live Tumor Board in Advanced Ovarian Cancer
September 03, 2026
02:00 PM - 03:00 PM ET
1.00 credits
Treatment Decisions That Matter: Live Tumor Board in Advanced Ovarian Cancer
CME/CE Virtual Event
Treatment Decisions That Matter: Live Tumor Board in Advanced Ovarian Cancer
September 24, 2026
03:30 PM - 04:30 PM ET
1.00 credits
Precision Through the Continuum: Applying Biomarker-Guided Therapies in Ovarian Cancer
CME/CE
Precision Through the Continuum: Applying Biomarker-Guided Therapies in Ovarian Cancer
- Susana Campos, MD, MPH
- Robert Coleman, MD, FACOG
- Debra Richardson, MD
1.00 credits
CME/CE In-Person & Virtual Event
Today’s CLL/SLL Decisions, Tomorrow’s Options: Practical Strategies for the Community Clinic
September 11, 2026
Houston, Texas
1.00 credits
Cracking the Code in Localized, nmCSPC: Risk, Treatment, and Timing
CME/CE
Cracking the Code in Localized, nmCSPC: Risk, Treatment, and Timing
- Neeraj Agarwal, MD, FASCO
- Rana McKay, MD
0.25 credits
advertisement
The Future of mCSPC: Molecular Profiling and Biomarker-Directed Therapies
CME/CE
The Future of mCSPC: Molecular Profiling and Biomarker-Directed Therapies
- Neeraj Agarwal, MD, FASCO
- Rana McKay, MD
0.25 credits
MinuteCE®
Treatment Intensification in HSPC: From Risk Stratification to Precision Medicine
- Scott T. Tagawa, MD, MS
- Mary-Ellen Taplin, MD
1.00 credits 6 episodes
De Novo mHSPC: Recognizing the Patients Who Need More
MinuteCE®
De Novo mHSPC: Recognizing the Patients Who Need More
- Scott T. Tagawa, MD, MS
- Mary-Ellen Taplin, MD
1.00 program credits
ADT Intensification: The Evidence You Can’t Afford to Miss
MinuteCE®
ADT Intensification: The Evidence You Can’t Afford to Miss
- Scott T. Tagawa, MD, MS
- Mary-Ellen Taplin, MD
1.00 program credits
Case: Implementing ADT Intensification in mHSPC
MinuteCE®
Case: Implementing ADT Intensification in mHSPC
- Scott T. Tagawa, MD, MS
- Mary-Ellen Taplin, MD
1.00 program credits
Winning the Battle Against Side Effects: Adverse Event Management in HSPC
MinuteCE®
Winning the Battle Against Side Effects: Adverse Event Management in HSPC
- Scott T. Tagawa, MD, MS
- Mary-Ellen Taplin, MD
1.00 program credits
advertisement
Molecular Profiling in mHSPC: Informing Treatment Selection
MinuteCE®
Molecular Profiling in mHSPC: Informing Treatment Selection
- Scott T. Tagawa, MD, MS
- Mary-Ellen Taplin, MD
1.00 program credits
Targeting PTEN: Why It Matters
MinuteCE®
Targeting PTEN: Why It Matters
- Scott T. Tagawa, MD, MS
- Mary-Ellen Taplin, MD
1.00 program credits
ELEVATE: Elacestrant Plus Capivasertib in Advanced Breast Cancer
MinuteCE®
ELEVATE: Elacestrant Plus Capivasertib in Advanced Breast Cancer
- Aditya Bardia, MD, MPH, FASCO
0.50 program credits

Program Chapters

Segment Chapters

Playlist:

Recommended